parallel randomized trial
S003067
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | Placebo Placebo | diet with 500 kcal daily deficit and activity advice; lifestyle: standard | 98 | 98 | |
| A2 | Liraglutide 1.2 mg subcutaneous once daily Liraglutide 1.2 mg | diet with 500 kcal daily deficit and activity advice; lifestyle: standard | 95 | 94 | |
| A3 | Liraglutide 1.8 mg subcutaneous once daily Liraglutide 1.8 mg | diet with 500 kcal daily deficit and activity advice; lifestyle: standard | 90 | 90 | |
| A4 | Liraglutide 2.4 mg injection once daily Liraglutide 2.4 mg | diet with 500 kcal daily deficit and activity advice; lifestyle: standard | 93 | 92 | |
| A5 | Liraglutide 3.0 mg subcutaneous once daily Liraglutide 3.0 mg | diet with 500 kcal daily deficit and activity advice; lifestyle: standard | 93 | 92 | |
| A6 | Orlistat Orlistat 120 mg three times daily | diet with 500 kcal daily deficit and activity advice; lifestyle: standard | 95 | 95 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Placebo A1 | Liraglutide 1.2 mg subcutaneous once daily A2 | Liraglutide 1.8 mg subcutaneous once daily A3 | Liraglutide 2.4 mg injection once daily A4 | Liraglutide 3.0 mg subcutaneous once daily A5 | Orlistat A6 |
|---|---|---|---|---|---|---|---|
| age | mean (years) | 45.9 | 47.2 | 45.5 | 45.0 | 45.9 | 45.9 |
| age | sd (years) | 10.3 | 9.7 | 10.9 | 11.1 | 10.7 | 9.1 |
| bmi | mean (kg/m2) | 34.9 | 34.8 | 35.0 | 35.0 | 34.8 | 34.1 |
| bmi | sd (kg/m2) | 2.8 | 2.6 | 2.6 | 2.8 | 2.8 | 2.6 |
| female | percent | 75 | 77 | 76 | 76 | 75 | 77 |
| hba1c | mean (percent) | 5.6 | 5.6 | 5.6 | 5.5 | 5.6 | 5.6 |
| hba1c | sd (percent) | 0.4 | 0.3 | 0.4 | 0.3 | 0.4 | 0.3 |
| sbp | mean (mmHg) | 124 | 127 | 123 | 126 | 124 | 123 |
| sbp | sd (mmHg) | 11.1 | 13.1 | 13.0 | 13.9 | 11.3 | 13.5 |
| waist | mean (cm) | 108 | 109 | 108 | 110 | 109 | 108 |
| waist | sd (cm) | 10.0 | 10.4 | 9.5 | 10.7 | 8.3 | 9.7 |
| weight | mean (kg) | 97.3 | 96.2 | 98.0 | 98.4 | 97.6 | 96.0 |
| weight | sd (kg) | 12.3 | 13.5 | 12.5 | 13.0 | 13.7 | 11.7 |
Analyses this trial contributes to
- Systolic blood pressure changeOverweight or obesity without diabetes (adults); weeks 40 to 104 (target week 68); network meta-analysis
- Systolic blood pressure changeOverweight or obesity without diabetes (adults); weeks 40 to 104 (target week 68); network meta-analysis
- Serious adverse eventsOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- Serious adverse eventsOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- NauseaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- NauseaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- VomitingOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- VomitingOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- DiarrheaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- DiarrheaOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- ConstipationOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
- ConstipationOverweight or obesity without diabetes (adults); longest follow-up; network meta-analysis
Results
82 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (28 lines; O05)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 52 | A1 | change | -1.6 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A1 | change | -0.2 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A2 | change | -4.2 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A2 | change | -3.9 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A2 vs A1 | md | -2.4 mmHg | -6.4 to 1.6 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A2 vs A1 | md | -3.7 mmHg | -8.1 to 0.8 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A2 vs A6 | md | -1.8 mmHg | -5.7 to 2.0 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A2 vs A6 | md | -2.1 mmHg | -6.6 to 2.5 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A3 | change | -4.0 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A3 | change | -2.8 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A3 vs A1 | md | -2.3 mmHg | -6.3 to 1.7 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A3 vs A1 | md | -2.6 mmHg | -7.1 to 2.0 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A3 vs A6 | md | -1.7 mmHg | -5.6 to 2.2 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A3 vs A6 | md | -1.0 mmHg | -5.6 to 3.7 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A4 | change | -7.0 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A4 | change | -6.3 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A4 vs A1 | md | -5.3 mmHg | -9.2 to -1.3 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A4 vs A1 | md | -6.0 mmHg | -10.5 to -1.6 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A4 vs A6 | md | -4.7 mmHg | -8.6 to -0.9 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A4 vs A6 | md | -4.4 mmHg | -9.0 to 0.1 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A5 | change | -4.9 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A5 | change | -5.4 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A5 vs A1 | md | -3.3 mmHg | -7.3 to 0.7 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A5 vs A1 | md | -5.2 mmHg | -9.5 to -0.8 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A5 vs A6 | md | -2.5 mmHg | -6.4 to 1.4 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A5 vs A6 | md | -3.6 mmHg | -8.1 to 0.9 | not stated; modified itt; R0025439:Supplement Table 3 | ||
| 52 | A6 | change | -2.3 mmHg | not stated; modified itt; R0025439:Supplement Table 3 | |||
| 52 | A6 | change | -1.8 mmHg | not stated; modified itt; R0025439:Supplement Table 3 |
Weight loss of 5 percent or more (6 lines; O11A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 52 | A1 | responders | 28 | 98 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A2 | responders | 43 | 94 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A3 | responders | 51 | 90 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A4 | responders | 53 | 92 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A5 | responders | 73 | 92 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A6 | responders | 44 | 95 | not stated; modified itt; R0025439:Figure 2 |
Weight loss of 10 percent or more (6 lines; O11B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 52 | A1 | responders | 10 | 98 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A2 | responders | 17 | 94 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A3 | responders | 26 | 90 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A4 | responders | 27 | 92 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A5 | responders | 37 | 92 | not stated; modified itt; R0025439:Figure 2 | ||
| 52 | A6 | responders | 14 | 95 | not stated; modified itt; R0025439:Figure 2 |
Physical functioning (any instrument) (6 lines; O24B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 52 | A1 | change | 8.7 points | 15 | not stated; modified itt; R0025439:Supplement Table 7 | ||
| 52 | A2 | change | 7.7 points | 13 | not stated; modified itt; R0025439:Supplement Table 7 | ||
| 52 | A3 | change | 11 points | 16 | not stated; modified itt; R0025439:Supplement Table 7 | ||
| 52 | A4 | change | 9.1 points | 16 | not stated; modified itt; R0025439:Supplement Table 7 | ||
| 52 | A5 | change | 14 points | 16 | not stated; modified itt; R0025439:Supplement Table 7 | ||
| 52 | A6 | change | 11 points | 12 | not stated; modified itt; R0025439:Supplement Table 7 |
Serious adverse events (6 lines; O25)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 3 / 98 | not stated; randomized; R0025439:Table 2 | ||||
| A2 | events | 2 / 95 | not stated; randomized; R0025439:Table 2 | ||||
| A3 | events | 7 / 90 | not stated; randomized; R0025439:Table 2 | ||||
| A4 | events | 4 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A5 | events | 7 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A6 | events | 2 / 95 | not stated; randomized; R0025439:Table 2 |
Discontinuation due to adverse events (6 lines; O26)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 3 / 98 | not stated; randomized; R0025439:Table 2 | ||||
| A2 | events | 5 / 95 | not stated; randomized; R0025439:Table 2 | ||||
| A3 | events | 6 / 90 | not stated; randomized; R0025439:Table 2 | ||||
| A4 | events | 12 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A5 | events | 7 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A6 | events | 3 / 95 | not stated; randomized; R0025439:Table 2 |
Nausea (6 lines; O27A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 7 / 98 | not stated; randomized; R0025439:Table 2 | ||||
| A2 | events | 23 / 95 | not stated; randomized; R0025439:Table 2 | ||||
| A3 | events | 29 / 90 | not stated; randomized; R0025439:Table 2 | ||||
| A4 | events | 35 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A5 | events | 45 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A6 | events | 7 / 95 | not stated; randomized; R0025439:Table 2 |
Vomiting (6 lines; O27B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 2 / 98 | not stated; randomized; R0025439:Table 2 | ||||
| A2 | events | 5 / 95 | not stated; randomized; R0025439:Table 2 | ||||
| A3 | events | 9 / 90 | not stated; randomized; R0025439:Table 2 | ||||
| A4 | events | 14 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A5 | events | 12 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A6 | events | 2 / 95 | not stated; randomized; R0025439:Table 2 |
Diarrhea (6 lines; O27C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 10 / 98 | not stated; randomized; R0025439:Table 2 | ||||
| A2 | events | 8 / 95 | not stated; randomized; R0025439:Table 2 | ||||
| A3 | events | 9 / 90 | not stated; randomized; R0025439:Table 2 | ||||
| A4 | events | 12 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A5 | events | 14 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A6 | events | 28 / 95 | not stated; randomized; R0025439:Table 2 |
Constipation (6 lines; O27D)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 12 / 98 | not stated; randomized; R0025439:Table 2 | ||||
| A2 | events | 15 / 95 | not stated; randomized; R0025439:Table 2 | ||||
| A3 | events | 11 / 90 | not stated; randomized; R0025439:Table 2 | ||||
| A4 | events | 21 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A5 | events | 17 / 93 | not stated; randomized; R0025439:Table 2 | ||||
| A6 | events | 7 / 95 | not stated; randomized; R0025439:Table 2 |